Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells $59,235.45 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CFO Alexis Desieno sold 7,451 shares of the stock in a transaction that occurred on Tuesday, July 2nd. The shares were sold at an average price of $7.95, for a total transaction of $59,235.45. Following the completion of the transaction, the chief financial officer now owns 6,898 shares in the company, valued at $54,839.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cardlytics Stock Performance

Shares of NASDAQ CDLX traded down $0.25 during mid-day trading on Tuesday, hitting $7.83. 750,273 shares of the company were exchanged, compared to its average volume of 1,368,857. The company has a quick ratio of 2.13, a current ratio of 2.13 and a debt-to-equity ratio of 1.30. The stock has a 50 day simple moving average of $9.89 and a 200-day simple moving average of $9.56. Cardlytics, Inc. has a 1-year low of $5.69 and a 1-year high of $20.52. The firm has a market cap of $381.95 million, a price-to-earnings ratio of -1.77 and a beta of 1.65.

Cardlytics (NASDAQ:CDLX) last released its earnings results on Wednesday, May 8th. The company reported ($0.35) EPS for the quarter. Cardlytics had a negative net margin of 55.23% and a negative return on equity of 25.36%. The business had revenue of $67.61 million during the quarter. On average, sell-side analysts forecast that Cardlytics, Inc. will post -1.8 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CDLX. Northland Securities started coverage on shares of Cardlytics in a research note on Tuesday, June 18th. They issued an “outperform” rating and a $14.00 price target on the stock. Bank of America restated a “neutral” rating and set a $11.00 target price on shares of Cardlytics in a research report on Thursday, June 20th. Needham & Company LLC restated a “buy” rating and set a $12.00 target price on shares of Cardlytics in a research report on Tuesday, June 11th. Craig Hallum lowered their target price on shares of Cardlytics from $18.00 to $12.00 and set a “buy” rating on the stock in a research report on Thursday, May 9th. Finally, Northland Capmk upgraded shares of Cardlytics to a “strong-buy” rating in a research report on Tuesday, June 18th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $12.67.

Institutional Investors Weigh In On Cardlytics

A number of hedge funds and other institutional investors have recently bought and sold shares of CDLX. Kent Lake Capital LLC acquired a new position in shares of Cardlytics during the 1st quarter worth $3,622,000. Blackstone Inc. acquired a new position in shares of Cardlytics during the 1st quarter worth $2,029,000. Perbak Capital Partners LLP acquired a new position in shares of Cardlytics during the 1st quarter worth $2,348,000. Price T Rowe Associates Inc. MD increased its position in Cardlytics by 6.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 29,769 shares of the company’s stock worth $432,000 after purchasing an additional 1,774 shares in the last quarter. Finally, Quadrature Capital Ltd purchased a new stake in Cardlytics during the 1st quarter worth about $1,906,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.